Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04983615
Other study ID # 0114-21-MMC
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 1, 2021
Est. completion date August 2025

Study information

Verified date October 2023
Source Meir Medical Center
Contact Sara Dichtwald, Dr
Phone 972-9-7472133
Email sara.dichtwald@clalit.org.il
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Opioid-based sedation as a first line in mechanically ventilated patients has been considered the "gold standard" in intensive care unit patients around the world for several decades. Advantages of opiate-based sedation, compared to benzodiazepine-based sedation, which has been used in the past, include a reduction in delirium scores, better pain control, decreasing the time between cessation of sedation and patient awakening, and decreasing the time between cessation of sedation and extubation, with decreased ICU admission times. In most Western European countries, as well as in the United States, there are almost no mechanically ventilated patients hospitalized outside the intensive care unit. In a few countries, including Japan and Israel, mechanically ventilated patients are also hospitalized outside of intensive care units, as part of internal or surgical wards. Contrary to the vast knowledge accumulated regarding different sedation methods in ventilated patients in intensive care units, there are almost no studies that have evaluated different sedation methods in ventilated patients hospitalized in non-intensive care wards. Thus, while there is consensus on the benefits of opioid-based sedation in intensive care units, there is insufficient information to recommend the preferred sedation method in non-ICU wards. For various reasons, in a large number of the internal medicine wards of hospitals in Israel, the common sedation practice for ventilated patients is still benzodiazepine-based sedation. In the past year, a pilot program was initiated in Internal Medicine Department A at Meir Hospital in Kfar Saba, in which a new protocol for opioid-based sedation in ventilated patients was implemented. The protocol is based on the continuous intravenous infusion of fentanyl as the first line of treatment for sedation in ventilated patients only. If the sedation-agitation level (as measured by the RASS score) did not match the target RASS score set by the attending physician, a dose up to a maximum limit could be increased according to the protocol. Second-line sedation drugs were addition of continuous intravenous infusion of midazolam (in addition to fentanyl) in hemodynamically stable patients, or addition of continuous intravenous infusion of ketamine in unstable patients. In stable patients who did not reach the desired RASS level under continuous infusion of fentanyl and midazolam, ketamine could be added as a third line drug, in addition to fentanyl and midazolam.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date August 2025
Est. primary completion date August 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria: Patients aged 18-99 who were admitted to Internal Medicine Department A at Meir Hospital in Kfar Saba from January 2020 to January 2021 (inclusive), and required mechanical ventilation. - Exclusion Criteria: Patients who were sedated and ventilated for palliative care only without any fututre plan for weaning them of ventilation, or patients in whom there was a deviation from the treatment protocol -

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
fentanyl-based sedation
fentanyl-based sedation instead of midazolam-based sedation in ventilated patients
midazolam-based sedation
midazolam-based sedation

Locations

Country Name City State
Israel Meir medical center Kfar Saba Kfar Saba

Sponsors (1)

Lead Sponsor Collaborator
Meir Medical Center

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary RASS score comparison of delirium score between the groups 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT06054503 - Pilot Clinical Investigation to Evaluate a Prototype of Sensor Measuring Ventilator-derived Parameters N/A
Completed NCT01997931 - The Impact of Bispectral Index Monitoring on Sedation Administration in Mechanically Ventilated Patients N/A
Completed NCT04134481 - Effect Of Clustered Nursing Interventions On Physiological Response In Critically Ill Patients
Completed NCT05588180 - The Ratio Of Femoral Vein Diameter To Femoral Artery Diameter With Pulse Pressure Variation As A Diagnostic Tool N/A
Recruiting NCT06153498 - PK/PD Properties and Safety of Remazolam Besylate for Injection in ICU Patients With Impaired Renal Function Phase 2
Recruiting NCT01256866 - Sedation of Mechanically Ventilated Critically Ill Patients: Midazolam Versus Dexmedetomidine Phase 4
Completed NCT01237886 - Weaning And Variability Evaluation N/A
Completed NCT00470821 - Oral Melatonin in Critically Ill High-risk Patients Phase 4
Completed NCT00322010 - Early Directed Physical Therapy in the Management of Mechanically Ventilated Patients in a Medical Intensive Care Unit Phase 2
Completed NCT01090258 - Pilot Evaluation of Closed Loop Ventilation and Oxygen Controller N/A
Completed NCT00199641 - Evaluation of Two Enteral Nutrition Strategies in Mechanically Ventilated Patients N/A
Not yet recruiting NCT06182553 - Effect of ERCC and/or PEEP-ZEEP Maneuver on Oxygenation, Ventilation, and Airway Secretions Removal in MV Patients N/A
Completed NCT03524937 - Prevention of Delirium in Intensive Care by Melatonin Phase 2/Phase 3
Completed NCT03333395 - Nebulized Heparin and Salbutamol in Mechanically Ventilated Patients With AECOPD Phase 4
Completed NCT05387720 - Concurrent Trigger Sensitivity Adjustment And Diaphragmatic Facilitation On Weaning From Mechanical Ventilation N/A
Recruiting NCT03800849 - Mechanical Ventilation Practices in Uganda's Intensive Care Units
Not yet recruiting NCT05480371 - Cough Assist Device in Mechanically Ventilated Patients N/A
Completed NCT06124404 - Step 1 of A Two-step Trial to Evaluate the Effectiveness and Safety of Remimazolam Besylate for Sedation in ICU Patients Phase 2
Completed NCT00935896 - High Tidal Volume Induces Inflammation In Normal Lungs N/A